Member Info for donotpanic

Results are due end of this Month

Look at all the buying... MMS know the news due they are only shaking the weak.. this will be back above 70's , I bet directors are itching their heads and wish they could buy but they can not as they are I think in closed period

Going BLUEEEEEEEEEEEEEEEEEEE

People relax... we ALL ready have contract with UK government ... NEWS end of this Month.. MMS just shaking and expect big RISE once they have collected the shares.

Its good when clueless are invested as when they panic sell... Buying opportunity appears.

Buyers showing RED

taking profits from low 40's and then game is on... 50 plus or even 52-53

Question here I been thinking even Vaccine is out should that not be given to patients who GOT COVID? To find who got COVID testing has to continue... May be silly question but had in my mind so decided to put it here. Also people travelling to or from other countries would still be tested?

Few buyers were shown RED... this is about to turn... This PRICE IS BUY PRICE ,TO cheap to buy and way to cheap to SELL.

ALL this panic on one article and people sold... Let's see who will be buying back now at HIGHER price... 50 will be blown soon

Are we ALL on Board as we are about to move towards 55-60.. TESTS are needed to years to come. Also they may make testing compulsory at AIRPORTS... Results end of this MONTH and MMS love MUGGING from the RISE... COULD BE BLUE DAY

https://www.pharmiweb.com/press-release/2020-11-12/covid-19-implications-of-early-vaccine-data

That is what MMS looking for sellers or shall I say weak HOLDERS... these shares are being taken from impatience and give to patience

It should not have been unexpected – we hoped for positive results from vaccine manufacturers this month, and we hope there is more to come, as AstraZeneca-Oxford University and Moderna are also due to announce initial results this month, and overall there are 11 vaccines in Phase III testing.

“However, these early results do not diminish the urgent need for COVID-19 treatments and testing, which will still be required for years to come. We consider the price falls to stocks such as Synairgen (-39%), Avacta (-36%), genedrive (-38%), Omega Diagnostics (-25%) and Open Orphan (-9%) to offer good buying opportunities.

“Even if a vaccine is perfectly effective, this will take years. Until then, the vast majority of the population will need to rely on treatments and testing for COVID-19.”

Omega is due to report half-year figures on 30 November.

https://dailybusinessgroup.co.uk/2020/11/db-live-covid-test-firms-oversold-economy-rebounds/

Omega remains on target to reach a production capacity of 300,000 lateral flow tests per week by the end of November, increasing to 500,000 tests per week by the end of December.

Did to one of my other shares and today went 15-20 percent up... this will be over 60 again.. No REASON for the DROP

Seems like they just rushed through the RNS... They could have started no reason for the DROP.. then speculation about press and then mention more about testing.. My average is now just over 0.50... DO ITOP UP OR WAIT ...

Giving me more to sell on Halifax...

About to be BLOWN... HERE WE COME 0.40